Implementation of RISE Risk Assessment Module at UAB Medicine

UAB Medicine's genetics team successfully implemented Genome Medical's RISE Risk Assessment Module to enhance cancer genetic services. This digital tool helps identify patients who meet genetic testing criteria, improving care efficiency and patient outcomes. With a seamless rollout in under six weeks, RISE has enabled UAB to better serve a diverse patient population, reduce wait times, and proactively identify at-risk patients, ultimately strengthening cancer care across multiple clinics.